Paper67885
An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
Halliday WJ and 3 others. Cancer Res, 1977. Cited by 41 papers, by iCite.
Cite this record
ConductScience Library. An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer. Papers, record 67885. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/67885
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.
- PubMed
Topics24
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Colonic Neoplasms | Major topic |
| Immunologic Techniques | Major topic |
| Leukocyte Adherence Inhibition Test | Major topic |
| Rectal Neoplasms | Major topic |
| Adult | |
| Aged | |
| Antibodies, Neoplasm | |
| Antigens, Neoplasm | |
| Binding, Competitive | |
| Diverticulum | |
| Epitopes | |
| Evaluation Studies as Topic | |
| False Positive Reactions | |
| Female | |
| Gastrointestinal Diseases | |
| Humans | |
| Immunity | |
| Immunity, Cellular | |
| Leukocytes | |
| Male | |
| Middle Aged | |
| Recurrence | |
| Remission, Spontaneous |
Source PubMed
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7059471 | Blood basophils in lung cancer. | Br J Cancer | 1982 | https://conductscience.org/library/papers/7059471 | PubMed |
| 6177329 | Cellular immunity to encephalitogenic peptide in tumour-bearing mice. | Br J Cancer | 1982 | https://conductscience.org/library/papers/6177329 | PubMed |
| 4042416 | Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms. | Clin Exp Immunol | 1985 | https://conductscience.org/library/papers/4042416 | PubMed |
| 3782265 | Leukocyte adherence inhibition in patients with nonmalignant disorders of the colon and colorectal cancer. | J Cancer Res Clin Oncol | 1986 | https://conductscience.org/library/papers/3782265 | PubMed |
| 3594486 | Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma. | Cancer Immunol Immunother | 1987 | https://conductscience.org/library/papers/3594486 | PubMed |
| 497111 | Bovine ocular squamous-cell carcinoma: lymphocyte response to phytohaemagglutinin and tumour antigen. | Br J Cancer | 1979 | https://conductscience.org/library/papers/497111 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/67885
GET https://conductscience.org/api/papers/v1/67885/authors